PUBLISHER: The Insight Partners | PRODUCT CODE: 1562278
PUBLISHER: The Insight Partners | PRODUCT CODE: 1562278
The Asia Pacific outpatient central fulfillment market was valued at US$ 50.60 million in 2022 and is expected to reach US$ 126.44 million by 2030; it is estimated to record a CAGR of 12.1% from 2022 to 2030.
Rising Aging Population and Emerging Markets Boosts Asia Pacific Outpatient Central Fulfillment Market
The aging population is a key to advancements in the healthcare sector. Thus, the growing aging population is anticipated to serve vital growth opportunity for the pharmacy. According to the United Nations World Population Prospects 2022 report, the elderly population is projected to increase from 10% of the total population in 2022 to 16% of the total population by 2050. The rapidly growing aging population indicates an exponential rise in demand for elderly care and medicines in the coming years. An upsurge in life expectancy worldwide has also led to the need for more digital and automated systems for adult care. The development of automatic medicine dispensers has served beneficially in developed regions. Advanced features such as an LED display, a motor controller, and an alarm system help people with medication reminders. Automated pharmacy systems would enable them to keep track of their medicine and stocks better. Further, implementing automated pharmacy systems has triggered adult medication adherence. With such features, the adoption of automated pharmacy systems is expected to grow in developing countries such as Japan, India, South Korea, and China in the coming years.
Pharmaceutical management is essential in developing countries owing to rising healthcare costs and pressure to improve access to pharmaceutical services. To ease access to drugs, governments of developing countries are adopting various strategies. Most market players focus on emerging markets such as China, India, and the UAE due to the surging prevalence of chronic diseases, rising adoption of the latest medical technologies in hospitals, and increasing awareness about advanced medical technologies.
Asia Pacific Outpatient Central Fulfillment Market Overview
China is the largest market for outpatient central fulfillment in Asia Pacific. The 13th Five-Year Plan of China that prioritized health and innovation has augmented demand for advanced medical devices. Moreover, the rising geriatric population and increasing chronic health conditions contribute to the outpatient central fulfillment market in this country. The availability of skilled laborers, low cost of operations, and massive space for production have further attracted the market leaders to have their production plants in China. Differences between the healthcare systems in China and other countries result in region-specific patterns of medical malpractice in China. Thus, the country has seen a significant rise in automated pharmaceutical dispensing, especially during the COVID-19 pandemic. In 2021, the Hospital of Changsha in the Hunan province was the first to install robotic pharmacy dispensing systems to enhance drug dispensing. Automation technologies are also widely used in the healthcare sector, leveraging demand for automated pharmacy systems. China is the largest exporter of active pharmaceutical ingredients to Western countries, requiring automation for the packaging and labeling of the products to be shipped. Production sites and warehouses have automated pharmacy systems installed in the manufacturing site.
Many startups in China are engaged in developing technologies for dispensing medicines. For instance, COBOT is a startup company that develops and markets smart systems for industrial robots. It has developed and commercialized a next-generation, smart medicine-dispensing robot. It can also automatically replenish stocks through a drug management system.
Asia Pacific Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Outpatient Central Fulfillment Market Segmentation
The Asia Pacific outpatient central fulfillment market is segmented based on product type, end user, and country. Based on product type, the Asia Pacific outpatient central fulfillment market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated tabletop counters, automated storage and retrieval systems, and others. The automated medication dispensing systems segment held the largest market share in 2022.
In terms of end user, the Asia Pacific outpatient central fulfillment market is segmented into hospital pharmacies, retail pharmacies, and mail-order pharmacies. The hospital pharmacies segment held the largest market share in 2022.
Based on country, the Asia Pacific outpatient central fulfillment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific outpatient central fulfillment market share in 2022.
Becton Dickinson and Co; Capsa Solutions, LLC; Cardinal Health Inc, McKesson Corp; and Omnicell Inc are some of the leading players operating in the Asia Pacific outpatient central fulfillment market.